Our results suggests that C/EBP-α, PGC-1α, and NF-κB are important to consider as potential biomarkers in the context of obesity and CRC, as their expression and methylation status could provide a new insight into how VAT is implicated in obesity-related CRC. This evidence concerns the gene PPARGC1A and obesity disorder.